At the news
? BULLISHIMPACT 6/10 PRESS-RELEASE filed Jul 29, 2026 at 10:00 ET
Smith+Nephew received FDA De Novo classification for its TESSA Spatial Surgery System, creating a new regulatory category for intra-articular orthopedic stereotaxic navigation instruments. The AI-powered augmented reality system is first indicated for ACL reconstruction surgery, addressing common tunnel placement errors. Commercial rollout begins Q3 2026.
- FDA granted De Novo classification for TESSA Spatial Surgery System, establishing first device in new FDA category for intra-articular orthopedic stereotaxic navigation instruments
- First indication is femoral anterior cruciate ligament reconstruction (ACLR) surgery, targeting femoral malposition (29%) and tibial malposition (11%) as common ACLR failure causes
- System uses AI, NVIDIA accelerated computing, AWS cloud deep-learning neural nets, and augmented reality for patient-specific 3D anatomical models overlaid on live 4K arthroscopic video
- Commercial introduction begins Q3 2026 with increased deployment expected in 2027
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access